3.0
May 25, 2012
Former employee, more than 5 years
San Francisco, CA
Recommend
CEO approval
Business Outlook
Pros
Well-managed company ranked 14 on Fortune 500. Generates a lot of cash, which fuels frequent acquisitions. Talented, deep leadership. Great execution in its core pharma distribution business.
Cons
Somewhat boring, low-margin business but with $130 billion in revenue, it does add up. As a B2B business, it's the biggest company no one's heard of. CEO's pay is ridiculously high.